Arrayit has been awarded two separate contracts for its microarray manufacturing services: one with the Centers for Disease Control and Prevention and another with Sandia National Laboratories.

Under the terms of the agreement with the CDC, announced last week, the company will manufacture peptide arrays for detecting infectious agents that could be used in a bioterror attack.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.